Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02375373 · ClinicalTrials.gov registry record

Effects of Adding Chickpeas to the American Diet (Long Term Study)

A clinical trial of Inflammation, sponsored by University of Florida.

Completed
Registry status
12
Enrollment target
1
Study location

NCT02375373 is a study of Inflammation that has completed, run by University of Florida. The registered enrollment target is 12 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02375373, a study of Inflammation, has completed, sponsored by University of Florida.

COMPLETED
Registry status
12 participants
Enrollment target
1
Study location

Study Summary

This prospective study will assess the effects of adding legumes, especially chick peas, to the diet of healthy adults on the commensal bacteria from feces of human subjects and resulting self-reported GI symptoms as well as markers of immune function.

Conditions Studied

Interventions

  • OTHER Observational Chickpea Diet

Study Locations (1)

Florida

  • Emerging Pathogens Institiute - Gainesville

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2015-04
Est. Completion 2015-12

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT02375373

The ClinicalTrials.gov registry entry for NCT02375373 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (96% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Inflammation appearing as the primary indexed condition, and to 1 intervention - of which Observational Chickpea Diet is the first listed.

NCT02375373 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT02375373 about?

NCT02375373 is a clinical study titled "Effects of Adding Chickpeas to the American Diet (Long Term Study)". This prospective study will assess the effects of adding legumes, especially chick peas, to the diet of healthy adults on the commensal bacteria from feces of human subjects and resulting self-reported GI symptoms as well as markers of immune function.

What is the current status of trial NCT02375373?

This trial is currently completed. The enrollment target is 12 participants. The study started on 2015-04. Estimated completion is 2015-12.

What conditions does trial NCT02375373 study?

This clinical trial studies the following conditions: Inflammation.

What interventions are being tested in trial NCT02375373?

The interventions under investigation include: Observational Chickpea Diet (OTHER).

Who is sponsoring clinical trial NCT02375373?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02375373 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.